SCHEMBL7790163

SCHEMBL7790163

COc1ccc(S(=O)(=O)NC(CC(=O)O)c2cccc(N(NC(=N)N)S(=O)(=O)c3ccccc3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
ATM Q13315 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KMT2A Q03164 2/20 0.45
EEF2K O00418 3/20 0.43
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41
MEN1 O00255 1/20 0.40
KEAP1 Q14145 2/20 0.39
NFE2L2 Q16236 1/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786192 0.89 EEF2K (0.52) ALDH1A1ATML3MBTL1KMT2AEEF2K
SCHEMBL7785635 0.87 ATM (0.52) ALDH1A1ATML3MBTL1KMT2AEEF2K
SCHEMBL7785658 0.87 LMNA (0.44) ALDH1A1KMT2AHCRTR1HCRTR2ITGB3
SCHEMBL7781105 0.85 EEF2K (0.47) ALDH1A1ATML3MBTL1EEF2KITGB3
SCHEMBL7785590 0.85 ATM (0.42) ALDH1A1ATML3MBTL1KMT2AEEF2K
SCHEMBL7187004 0.84 MAPT (0.48) ALDH1A1ATML3MBTL1KMT2AEEF2K
SCHEMBL7785607 0.84 LMNA (0.46) ALDH1A1KMT2AITGB3ITGAVMEN1
SCHEMBL7785619 0.83 ATM (0.42) ALDH1A1ATML3MBTL1EEF2KITGB3
SCHEMBL7785625 0.82 EEF2K (0.41) ALDH1A1ATML3MBTL1KMT2AEEF2K
SCHEMBL7789956 0.81 EEF2K (0.39) ALDH1A1ATML3MBTL1KMT2AEEF2K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed